Full disclosure: GSK’s pledge to open clinical trial data
In efforts to deflect criticism, GSK announced in October 2012 that it would make detailed data from clinical trials available…
In efforts to deflect criticism, GSK announced in October 2012 that it would make detailed data from clinical trials available…
An unprecedented cycle of drug patent expiries is putting financial pressure on big pharma as previously rock-solid revenue streams begin…